Vimarsana
Biggest News Aggregation in the World

Page 7 - Mostread Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mostread Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mostread Technology Today - Breaking & Trending Today

Darktrace lifts, focuses full-year guidance - Vimarsana News

Darktrace lifts, focuses full-year guidance

Cybersecurity specialist Darktrace reported solid growth in both operating and financial metrics in the March quarter on Thursday, as it raised its full-year guidance.

Iomart flags decent results, warns of lower-than-expected renewals - Vimarsana News

Iomart flags decent results, warns of lower-than-expected renewals

Secure cloud service provider Iomart said in an update on Thursday that, despite a challenging economic environment, it expected to deliver a robust set of full-year results for the 12 months ended 31 March.

IQE confident in recovery as it expands AWSC partnership - Vimarsana News

IQE confident in recovery as it expands AWSC partnership

Semiconductor wafer and advanced material specialist IQE announced its results for the year ended 31 December on Wednesday, alongside announcing an expansion of its partnership with Advanced Wireless Semiconductor Company (AWSC).

Epwin reports strong year despite market challenges - Vimarsana News

Epwin reports strong year despite market challenges

Energy-efficient and low-maintenance building products specialist Epwin Group said in its final results on Wednesday that, despite challenges posed by raw material cost inflation and market volatility, it delivered a strong performance, with revenue totalling £345.4m and underlying operating profit reaching £25.5m, marking a 19% increase over the prior year.

4basebio to provide synthetic DNA to tier-one pharma firm - Vimarsana News

4basebio to provide synthetic DNA to tier-one pharma firm

4basebio confirmed the provision of its synthetic DNA to an unnamed tier-one pharmaceutical company on Wednesday.